| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/02/2005 | US6924280 Dipeptide derivatives |
| 08/02/2005 | US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases |
| 08/02/2005 | US6924277 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases |
| 08/02/2005 | US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6924100 Nucleotide sequences coding preferential polypeptide for use in the treatment and diagnosis of cardiovascular disorders and headaches |
| 08/02/2005 | US6923988 Solid carrier includes a hydrophililc surfactant and a drug |
| 08/02/2005 | CA2325358C 7-¬(4'-trifluoromethyl-biphenyl-2-carbonyl)amino|-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein b |
| 08/02/2005 | CA2321639C Bicyclo[2.2.1]heptanes and related compounds |
| 08/02/2005 | CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities |
| 08/02/2005 | CA2154577C Novel inhibitors of adenosine monophosphate deaminase |
| 07/28/2005 | WO2005068490A1 Inclusion complexes of perindopril |
| 07/28/2005 | WO2005068467A1 Novel fused-ring compound |
| 07/28/2005 | WO2005068425A1 New crystalline form of perindopril |
| 07/28/2005 | WO2005067975A1 Title: a sustained release captopril formulation having a supermolecular intercalation structure and the preparation process thereof |
| 07/28/2005 | WO2005067904A1 Abca1 stabilizer |
| 07/28/2005 | WO2005034866A3 Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors |
| 07/28/2005 | WO2004093828A3 Reverse-turn mimetics and method relating thereto |
| 07/28/2005 | WO2004087734A3 Stq-peptides |
| 07/28/2005 | WO2004033620A3 Methods and compositions for therapeutic use of rna interference |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | WO2002055010A3 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/28/2005 | US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles |
| 07/28/2005 | US20050165118 Hypotensive agents; antiinflammatory agents; gastrointestinal disorders; autoimmune disease; 4-phenyl pinene derivatives |
| 07/28/2005 | US20050165113 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | US20050165103 for enhancing the endogenous production of interleukin-10 (IL-10) and suppressing the production of interleukin-2 in mammalian cells or tissues; inhibiting the proliferation of stimulated peripheral mononuclear cells |
| 07/28/2005 | US20050165094 Chemical compounds containing a superoxide scavenger and an organic nitrate or nitrite moiety |
| 07/28/2005 | US20050165091 includes a buffering agent to stabilize and maintain the pH below 9 in an aqueous dispersion; slow the degradation; shelf-life |
| 07/28/2005 | US20050165087 Nf-kb inhibitors |
| 07/28/2005 | US20050165086 Aminothiophene inhibitors of NF- kappa B inhibitors for treatment of diseases such as cancer or aids |
| 07/28/2005 | US20050165064 Novel thiol derivative, process for producing the same and use thereof |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050165057 cholesterol acyl transferase inhibitor for treatment of hyperlipidemia and atherosclerosis; piperidin-4-yl]methyl urea derivatives |
| 07/28/2005 | US20050165045 Compounds and methods |
| 07/28/2005 | US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/28/2005 | US20050165036 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 07/28/2005 | US20050165030 Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 07/28/2005 | US20050165022 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/28/2005 | US20050165021 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| 07/28/2005 | US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 07/28/2005 | US20050165017 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165011 6-[5-(6-methyl-pyridin-2-yl)-1H-[1,2,3]triazol-4-yl]-4H-benzo[1,4]oxazin-3-one, used as inhibitors of the transforming growth factor beta-signalling pathways, in particular, the phosphorylation of smad gene and proteins or activin-like kinase receptors; prophylaxis of kidney fibrosis |
| 07/28/2005 | US20050165008 7-chloro-4-(2-fluoroethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide; AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid)modulators; antidepressant, anxiolytic agent |
| 07/28/2005 | US20050164995 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 07/28/2005 | US20050164988 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 07/28/2005 | US20050164936 Antiinflammatory and antitumor agents; human T-cell leukemia/lymphoma virus and lymphadenopathy associated virus treatment; angiogenic- or hematopoiesis-related diseases; medical diagnosis |
| 07/28/2005 | US20050164926 Novel recombinant anticoagulant proteins |
| 07/28/2005 | US20050164917 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2005 | US20050164382 Differentiation protocol for making human cardiomyocytes |
| 07/28/2005 | US20050164366 Tissue plasminogen activator-like protease |
| 07/28/2005 | US20050164305 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 07/28/2005 | US20050164298 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor(ghs) |
| 07/28/2005 | US20050164263 identification of amino acid sequences and proteins related to MAP/ERK subfamily; gene chip; transgenic nonhuman animal; nucleic acid vector; expression in larynx epithelium, Wilms' tumors of the kidney, pancreas adenocarcinomas, fetal brain, and hippocampus; models for human therapeutic targets |
| 07/28/2005 | US20050164233 Compositions, kits and methods for identification and modulation of type I diabetes |
| 07/28/2005 | US20050164183 Adipocyte differentiation-associated gene and protein |
| 07/28/2005 | US20050163778 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/28/2005 | US20050163727 Topical, oral administration; mouthrinses; microbiocides; bactericides; prevents spread of pathogenic oral bacteria, toxins and endotoxins, and resultant inflammatory cytokines and mediators; cardiovascular disease, stroke, atherosclerosis |
| 07/28/2005 | DE4243381B4 3(2H)-Pyridazinonderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie diese enthaltende Arzneimittel und ihre Verwendung 3 (2H) -pyridazinone derivatives, processes and intermediates for their preparation and pharmaceutical compositions containing them and their use |
| 07/28/2005 | CA2553710A1 Abca1 stabilizer |
| 07/28/2005 | CA2553329A1 New fused polycyclic compounds |
| 07/28/2005 | CA2553202A1 Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/28/2005 | CA2552664A1 Methods for treating and preventing hypertension and hypertension-related disorders |
| 07/28/2005 | CA2552471A1 Combination of crf antagonists and 5-ht 1b receptor antagonists |
| 07/28/2005 | CA2551948A1 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors |
| 07/27/2005 | EP1557430A1 Antibody and utilization of the same |
| 07/27/2005 | EP1557414A1 Isoquinoline compounds and medicinal use thereof |
| 07/27/2005 | EP1557412A1 Fluorinated benzothiadiazine derivatives and their use as AMPA receptor modulators |
| 07/27/2005 | EP1557409A1 5HT2C receptor modulators |
| 07/27/2005 | EP1557407A1 Novel alpha-ketoamide derivative and use thereof |
| 07/27/2005 | EP1557183A1 Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis |
| 07/27/2005 | EP1557174A1 Composition containing eosinophil cationic protein |
| 07/27/2005 | EP1556705A2 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
| 07/27/2005 | EP1556494A2 Bicistronic vector encoding a vegf and an fgf, use thereof |
| 07/27/2005 | EP1556406A1 Derivatives comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease |
| 07/27/2005 | EP1556357A1 Compounds, compositions, and methods |
| 07/27/2005 | EP1556355A1 Inhibitors of glycogen synthase kinase 3 |
| 07/27/2005 | EP1556353A1 Diaryl compounds as monoamine reuptake inhibitors |
| 07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
| 07/27/2005 | EP1556344A1 Treating syndrome x with substituted tetralins and indanes |
| 07/27/2005 | EP1556080A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556040A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | EP1556025A1 Compositions comprising vitamin k for treating or preventing age-related stiffening of arteries |
| 07/27/2005 | EP1555894A2 Novel neutracetical and pharmaceutical compositions and their uses |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | EP1377573B1 Pyrazolopyridine derivatives |
| 07/27/2005 | EP1351961B1 Substituted indolines as 5-ht receptor ligands |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1318992B1 Imidazole derivatives as raf kinase inhibitors |
| 07/27/2005 | EP1315723B1 The hydrochloride salt of 5[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 07/27/2005 | EP1313736B1 Condensed pyrazindione derivatives as inhibitors of pde5 |
| 07/27/2005 | EP1309555B1 Process for making amlodipine maleate |
| 07/27/2005 | EP1289559B1 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/27/2005 | EP1283823A4 Novel mmp-2/mmp-9 inhibitors |
| 07/27/2005 | EP1274411B1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |